Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Supplementation of chitosan oligosaccharides(COS) could ameliorate severity of pancreatic injury, prevent intestinal barrier disruption and reduce inflammatory and oxidative injury in severe acute pancreatitis (SAP). The protective mechanism partly attributed to the reshaping of gut microbiota and TLR4 and Nrf2/HO-1 pathway.